Antivertigo agents. V. Quantitative structure-activity relationships of 6-[2-(4-aryl-1-piperazinyl)ethyl]-5,6,7,8-tetrahydro-1,6-naphthyridine s.
D000818:Animals; D002415:Cats; D055598:Chemical Phenomena; D002621:Chemistry; D009682:Magnetic Resonance Spectroscopy; D009287:Naphthyridines / Q000138:chemical synthesis* / Q000494:pharmacology; D010879:Piperazines / Q000138:chemical synthesis* / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014717:Vertigo / Q000188:drug therapy*
D009287:Naphthyridines; D010879:Piperazines